학술논문
Discovery of 4-((2 S,4 S)-4-Ethoxy-1-((5-methoxy-7-methyl-1 H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed to Be Applicable to Treating a Diverse Array of Complement Mediated Diseases
Document Type
Article
Author
Mainolfi, N.; Ehara, T.; Karki, R.G.; Anderson, K.; Liao, S.-M.; Argikar, U.A.; Jendza, K.; Zhang, C.; Powers, J.; Klosowski, D.W.; Crowley, M.; Kawanami, T.; Ding, J.; April, M.; Forster, C.; Serrano-Wu, M.; Capparelli, M.; Solovay, C.; Smith, T.M.; Ferrara, L.; Lee, W.; Long, D.; Prentiss, M.; De Erkenez, A.; Yang, L.; Liu, F.; Mogi, M.; Jaffee, B.D.; Adams, C.M.; Mac Sweeney, A.; Ramqaj, R.; Cumin, F.; Sellner, H.; Sirockin, F.; Valeur, E.; Erbel, P.; Ostermeier, D.; Ramage, P.; Gerhartz, B.; Schubart, A.; Flohr, S.; Gradoux, N.; Feifel, R.; Vogg, B.; Wiesmann, C.; Maibaum, J.; Eder, J.; Sedrani, R.; Harrison, R.A.
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 11 June 2020, 63(11):5697-5722)
Subject
Language
English
ISSN
15204804
00222623
00222623